Combination of recombinant human endostatin and TACE in treatment of primary hepatic cancer and parameter changes of CT perfusion[J]. Journal of Clinical Medicine in Practice, 2014, (23): 73-76. DOI: 10.7619/jcmp.201423024
Citation:
|
Combination of recombinant human endostatin and TACE in treatment of primary hepatic cancer and parameter changes of CT perfusion[J]. Journal of Clinical Medicine in Practice, 2014, (23): 73-76. DOI: 10.7619/jcmp.201423024
|
Combination of recombinant human endostatin and TACE in treatment of primary hepatic cancer and parameter changes of CT perfusion[J]. Journal of Clinical Medicine in Practice, 2014, (23): 73-76. DOI: 10.7619/jcmp.201423024
Citation:
|
Combination of recombinant human endostatin and TACE in treatment of primary hepatic cancer and parameter changes of CT perfusion[J]. Journal of Clinical Medicine in Practice, 2014, (23): 73-76. DOI: 10.7619/jcmp.201423024
|